Bleakley Financial Group, LLC Maravai Lifesciences Holdings, Inc. Transaction History

Bleakley Financial Group, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 27, 2025	BUY	$4.42 - $8.5 $42,683 - $82,084	9,657 Added 30.15%	41,691 $227 Million
Q3 2024 Oct 16, 2024	BUY	$6.84 - $9.73 $60,622 - $86,236	8,863 Added 38.25%	32,034 $266 Million
Q2 2024 Aug 12, 2024	SELL	$6.87 - $11.34 $44,256 - $73,052	-6,442 Reduced 21.75%	23,171 $166 Million
Q1 2024 May 08, 2024	BUY	$5.11 - $8.76 $29,908 - $51,272	5,853 Added 24.63%	29,613 $257 Million
Q4 2023 Jan 25, 2024	BUY	$4.7 - $9.87 $50,741 - $106,556	10,796 Added 83.28%	23,760 $156 Million

Q3 2023 Nov 14, 2023	BUY	$9.14 - $12.85 $118,490 - $166,587	12,964 New	12,964 $130 Million

182

132M

688K

11.6K

Ticker MRVI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 131,540,000
Market Cap $479M
Description
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...

Get notified when there are updates to the investment portfolio of Bleakley Financial Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Bleakley Financial Group, LLC with notifications on news.